Liz Parrish and 2yr follow-up from telomerase gene therapy Liz Parrish, founder of BioViva Sciences discusses the objective improvements in her biomarkers after taking gene therapy for telomerase and follastatin. Read More Ed Park, MD 02/05/2018 No Comments